Scientific Reports-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-04-20 ms2000000753740027 来自上海

👍很棒的介绍

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-03-12 ms9000001661382603 来自四川省

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：分子;细胞
经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了
Submission history
Peer review
Submission status Date
Submission under peer review
06 Oct 2023
Technical check
Submission status Date
Submission passed technical check
06 Oct 2023
Amendment received
06 Oct 2023
Submission is under technical check
18 Sep 2023
Submission received
Submission status Date
Submission received
18 Sep 2023

18 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-03-22 ms7000000307422374 来自福建省

两个月还没找到审稿人

17 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-04-17 ms7000000714401863 来自康涅狄格

请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-01-02 Dehors 来自江苏省

偏重的研究方向：生物信息学;肿瘤;Cancer
经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report)

66 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2023-12-06 发大文章带我一个二十作吧来自上海

想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks.

51 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2023-07-28 ms5000000683483699 来自山东省

偏重的研究方向：生物信息学;肿瘤
经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了

58 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-03-28 萝布来自湖北省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：基础
经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。

11 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-03-04 ms7957059236203375 来自四川省

偏重的研究方向：肿瘤
经验分享：一月份投，二月份就接收了，有没有想问的！

64 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2199413, encodeId=ca0c2199413ac, content=👍很棒的介绍 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1dbc9170714, createdName=ms2000000753740027, createdTime=Sat Apr 20 08:10:56 CST 2024, time=2024-04-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192732, encodeId=d4962192e3210, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：分子;细胞 经验分享：23年9月开始投的，一直到现在24.3.12都一直没用动静，之前是18个同行评审，现在也看不见，中途出现过一个审稿人意见，只有一个，但是系统上看不见，现在也没有显示有审稿意见了，这也太慢了，都想投其他期刊了，又感觉等这么久就白费了 Submission history Peer review Submission status Date Submission under peer review 06 Oct 2023 Technical check Submission status Date Submission passed technical check 06 Oct 2023 Amendment received 06 Oct 2023 Submission is under technical check 18 Sep 2023 Submission received Submission status Date Submission received 18 Sep 2023, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4248263748, createdName=ms9000001661382603, createdTime=Tue Mar 12 11:13:29 CST 2024, time=2024-03-12, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2194666, encodeId=710421946668f, content=两个月还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fab6517805, createdName=ms7000000307422374, createdTime=Fri Mar 22 13:19:23 CST 2024, time=2024-03-22, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2198891, encodeId=7270219889143, content=请问一下大家在track snapp submission界面看是pass technical checks, 然后点view submission details看是under peer review，中间没有任何invite editor和invite reviewer的消息，请问这个是怎么回事呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa3d9260658, createdName=ms7000000714401863, createdTime=Wed Apr 17 04:05:25 CST 2024, time=2024-04-17, status=1, ipAttribution=康涅狄格), GetPortalCommentsPageByObjectIdResponse(id=2178836, encodeId=212721e883660, content=偏重的研究方向：生物信息学;肿瘤;Cancer 经验分享：- [ ] 2023.12.26 submission received - [ ] 2023.12.26 submission is under technical check - [ ] 2023.12.27 submission passed technical check - [ ] 2023.12.27 editor invited - [ ] 2023.12.27 editor assigned - [ ] 2023.12.27 reviewers invited(3) - [ ] 2023.12.27 1 reviewer(s) accepted - [ ] 2023.12.30 2 reviewer(s) accepted (Awaiting their report), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240102/21c3548d3cdf4d768708708330c1b141/805c04b8c592400eb28358eb81f1a145.jpg, createdBy=4a299119890, createdName=Dehors, createdTime=Tue Jan 02 18:33:59 CST 2024, time=2024-01-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2173392, encodeId=267721e339254, content=想问下大佬们，到这个阶段之后，后续会有editer has been invited 或者多少多少reviewers has been invited吗？还是就过几个礼拜直接到decision了？ We will now find the most suitable editor to manage the next steps of your submission. If your submission is successful, they will invite reviewers to peer review your work. This process can take a few weeks., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230712/7b1f2dc9a324479e9877047bc3d85ecd/b95cd487c3e24b4d8bfa2fc6ab30880c.jpg, createdBy=aed48754576, createdName=发大文章带我一个二十作吧, createdTime=Wed Dec 06 23:30:26 CST 2023, time=2023-12-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2150320, encodeId=3ba1215032042, content=偏重的研究方向：生物信息学;肿瘤 经验分享：大家一般邀请几个审稿人啊，我邀请了五个，都接受审稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c178590765, createdName=ms5000000683483699, createdTime=Fri Jul 28 23:15:56 CST 2023, time=2023-07-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195926, encodeId=31e8219592616, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：基础 经验分享：2023年6月4日投稿，2024年3月25日接收。9个多月，终于过关了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a26a1720733, createdName=萝布, createdTime=Thu Mar 28 19:54:17 CST 2024, time=2024-03-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2190854, encodeId=5fbd2190854e9, content=偏重的研究方向：肿瘤 经验分享：一月份投，二月份就接收了，有没有想问的！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqpapZYXCJZ2AkkJ5Gps0ysAzZE4zgb2VXFGn2ZHyMj98TIQpsx3yxTicaD0m42xk9m1vRtBPgS7TQ/132, createdBy=4b552425875, createdName=ms7957059236203375, createdTime=Mon Mar 04 08:08:15 CST 2024, time=2024-03-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2195331, encodeId=7d1721953317b, content=这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37258600832, createdName=ms2000001772107411, createdTime=Mon Mar 25 22:14:07 CST 2024, time=2024-03-25, status=1, ipAttribution=广东省)]

2024-03-25 ms2000001772107411 来自广东省

这个期刊会desk jeject吗？水平还ok，可能创新性一般，写的时候有篇类似的online了

13 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务